Eventos
Sorafenib downregulates nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression impacting cell survival in liver cancer cells
Sorafenib downregulates nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression impacting cell survival in liver cancer cells
| Título | Sorafenib downregulates nuclear factor E2-related factor 2 (Nrf2)-regulated thioredoxin 1 (Trx1) expression impacting cell survival in liver cancer cells | 
|---|---|
| Fecha event | 26/10/2022 08:30 → 26/10/2022 10:00 | 
| Entidad | IBiS | 
| Lugar | Salón de Actos IBiS | 
| Organizador | IBiS | 
| Ponentes | Dr. Jordi Muntané Co-Investigador Responsable Grupo IBiS Cirugía Oncológica. Terapia celular y trasplante de órganos | 
| Cartel/Poster |   |